EUVIMEDEUVIMED entdecken
Studienprotokoll

Efficacy of a Chlorhexidine-Based Oral Prevention Protocol in Reducing Ventilator-Associated Pneumonia in Pediatrics: A Controlled Before-After Study

Ivonne Portaccio iD, Orazio Genovese, Federico De Leonardis, Ilaria Vitali, Enzo Picconi, Tony Christian Morena, Federica Tosi, Audrey Marie Orr, Artiom Noto, Giorgia Spinazzola, Rita Murri, Giorgio Conti und 1 weitere

Journal of Intensive Care Medicine · 2026-12 · 41 (12) · 1275-1286

DOI: 10.1177/08850666261440187 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of Intensive Care Medicine, online erschienen am 10.04.2026. Verfasst von Ivonne Portaccio und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Intensive Care Unit and Trauma Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Pneumonia, Ventilator-Associated, Chlorhexidine, Oral Hygiene, Anti-Infective Agents, Local. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ventilator-associated pneumonia (VAP) remains the second most common nosocomial infection in pediatric intensive care units, yet evidence-based prevention strategies specific to children remain limited.

Objective

To evaluate the efficacy of a multimodal VAP prevention bundle incorporating 0.12% chlorhexidine oral care in reducing VAP incidence among mechanically ventilated pediatric patients.

Methods

Controlled before-after study in the Gemelli PICU (January 2016-May 2019) including 162 patients aged 2 years, saline for younger children), head-of-bed elevation 30°-40°, biweekly microbiological surveillance, and daily weaning assessment. Primary outcome was VAP incidence using CDC/NHSN criteria.

Results

Bundle implementation was associated with a 69.5% reduction in VAP incidence (20% to 6.1%, P = .01), decreasing from 3.3 to 1.0 VAP/100 ventilator-days. The number needed to treat was 7.2 patients. Protocol implementation reduced VAP risk (adjusted OR 0.23; 95% CI 0.07-0.81; P = .022). VAP-associated mortality was lower in the intervention group (0% vs 3.8% in controls). Duration of mechanical ventilation remained the strongest risk factor (OR 1.18 per day; 95% CI 1.08-1.29; P < .001). Pseudomonas aeruginosa was identified in 57.1% of VAP cases, with polymicrobial infections in 52.4%. All isolates remained antibiotic-susceptible.

Conclusions

Structured implementation of an evidence-based VAP bundle may contribute to significant reductions in preventable VAP in pediatric intensive care. While findings are promising, the modest sample size necessitates cautious interpretation and validation through larger multicenter studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, Ventilator-AssociatedChlorhexidineOral HygieneAnti-Infective Agents, LocalHumansFemaleIntensive Care Units, PediatricChildChild, PreschoolInfantMaleRespiration, ArtificialControlled Before-After StudiesAdolescentIncidenceCross Infection

Stichwörter der Autor:innen

bundlechlorhexidineintensive carepediatricspreventionventilator-associated pneumonia

Substanzen

ChlorhexidineAnti-Infective Agents, Local

Autor:innen und Institutionen

  • Pediatric Intensive Care Unit and Trauma Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
  • Institute of Anesthesia and Intensive Care, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Institute of Infectious Diseases, Università Cattolica del Sacro Cuore, Rome, Italy.

ORCID-Profile: Ivonne Portaccio

Zitieren

APA

Portaccio, I., Genovese, O., De Leonardis, F., Vitali, I., Picconi, E., Morena, T. C., Tosi, F., Orr, A. M., Noto, A., Spinazzola, G., Murri, R., Conti, G., & Piastra, M. (2026). Efficacy of a Chlorhexidine-Based Oral Prevention Protocol in Reducing Ventilator-Associated Pneumonia in Pediatrics: A Controlled Before-After Study. Journal of Intensive Care Medicine, 41(12), 1275-1286. https://doi.org/10.1177/08850666261440187

Vancouver

Portaccio I, Genovese O, De Leonardis F, Vitali I, Picconi E, Morena TC, et al. Efficacy of a Chlorhexidine-Based Oral Prevention Protocol in Reducing Ventilator-Associated Pneumonia in Pediatrics: A Controlled Before-After Study. Journal of Intensive Care Medicine. 2026;41(12):1275-1286. doi:10.1177/08850666261440187

BibTeX
@article{Portaccio2026,
  author = {Portaccio, Ivonne and Genovese, Orazio and De Leonardis, Federico and Vitali, Ilaria and Picconi, Enzo and Morena, Tony Christian and Tosi, Federica and Orr, Audrey Marie and Noto, Artiom and Spinazzola, Giorgia and Murri, Rita and Conti, Giorgio and Piastra, Marco},
  title = {Efficacy of a Chlorhexidine-Based Oral Prevention Protocol in Reducing Ventilator-Associated Pneumonia in Pediatrics: A Controlled Before-After Study},
  journal = {Journal of Intensive Care Medicine},
  year = {2026},
  volume = {41},
  number = {12},
  pages = {1275--1286},
  doi = {10.1177/08850666261440187}
}
Kostenlos starten →